News & Updates

TKI-ICI combo offers hope for prostate cancer patients with poor prognosis

29 Feb 2024 by

A combination of the TKI* cabozantinib and ICI** atezolizumab improved progression-free survival (PFS) in men with metastatic castration-resistant prostate cancer (mCRPC) with measurable extrapelvic nodal or visceral metastasis who progressed on prior novel hormonal therapy (NHT), findings from the phase III CONTACT-02 trial have shown.

TKI-ICI combo offers hope for prostate cancer patients with poor prognosis

29 Feb 2024

Investigational drug scores big in mild-to-moderate AD, plaque psoriasis

29 Feb 2024

The topical phosphodiesterase 4 inhibitor PF-07038124 is safe and helps lower disease activity in patients with mild-to-moderate atopic dermatitis (AD) and plaque psoriasis, according to the results of a phase IIa study.

Investigational drug scores big in mild-to-moderate AD, plaque psoriasis

29 Feb 2024

HKUMed’s new leadership team poised to reach new heights

29 Feb 2024 by

The new leadership team of LKS Faculty of Medicine of the University of Hong Kong (HKUMed), led by Dean of Medicine, Professor Chak-Sing Lau, is poised to reach new heights in medical education and research through extensive development plans.

HKUMed’s new leadership team poised to reach new heights

29 Feb 2024

Greater weight loss associated with higher likelihood of T2DM remission

29 Feb 2024 by

A population-based observational cohort study of >37,000 people in Hong Kong shows that greater weight loss within the first year of type 2 diabetes mellitus (T2DM) diagnosis is associated with an increased likelihood of achieving and sustaining diabetes remission.

Greater weight loss associated with higher likelihood of T2DM remission

29 Feb 2024

People with vision impairment prone to psychosocial problems

28 Feb 2024

Vision impairment appears to contribute to several psychosocial outcomes, including depression, anxiety, and social isolation, according to a study.

People with vision impairment prone to psychosocial problems

28 Feb 2024

Experimental COVID-19 drug shows promising antiviral efficacy in Asians

28 Feb 2024 by

The oral SARS-CoV-2 3C-like protease inhibitor ensitrelvir fumaric acid helps speed up recovery time for COVID-19 symptoms in patients with mild-to-moderate infection, according to the phase III data from the phase II/III SCORPIO-SR study conducted in Asia.

Experimental COVID-19 drug shows promising antiviral efficacy in Asians

28 Feb 2024

Loading, maintenance doses of teicoplanin need adjustments in MRSA patients

28 Feb 2024

A recent study recommends adjusting both loading dosing and maintenance dosing regimens of teicoplanin based on the renal function and serum albumin concentration of patients with methicillin-resistant staphylococcus aureus (MRSA) infection.

Loading, maintenance doses of teicoplanin need adjustments in MRSA patients

28 Feb 2024

Share decision-making process with patients, says study

28 Feb 2024 by

Many Singaporeans believe that decision-making should be shared between medical professionals and patients, as shown by the results of a cross-sectional survey. Both the education level and employment status of patients have influence on decision-making.

Share decision-making process with patients, says study

28 Feb 2024

Modern urethroplasty offers long-term patency, patient satisfaction

28 Feb 2024

Contemporary urethroplasty delivers high long-term patency and satisfaction to patients undergoing such a procedure, a recent study confirms. Moreover, those with longer stricture, lichen sclerosus, radiation, and infectious aetiologies are at greater risk of stricture recurrence in the future.

Modern urethroplasty offers long-term patency, patient satisfaction

28 Feb 2024

Adjuvant pembrolizumab holds promise in bladder cancer

28 Feb 2024 by

The phase III AMBASSADOR Alliance A031501 trial showed a statistically significant and clinically meaningful improvement in disease-free survival (DFS) with adjuvant pembrolizumab compared with observation in patients with high-risk locally advanced muscle-invasive urothelial carcinoma (MIUC) after radical surgery regardless of PD-L1 status.

Adjuvant pembrolizumab holds promise in bladder cancer

28 Feb 2024

News & Updates

Filter by Specialty:

Specialty:

TKI-ICI combo offers hope for prostate cancer patients with poor prognosis

TKI-ICI combo offers hope for prostate cancer patients with poor prognosis

Investigational drug scores big in mild-to-moderate AD, plaque psoriasis

Investigational drug scores big in mild-to-moderate AD, plaque psoriasis

HKUMed’s new leadership team poised to reach new heights

HKUMed’s new leadership team poised to reach new heights

Greater weight loss associated with higher likelihood of T2DM remission

Greater weight loss associated with higher likelihood of T2DM remission

People with vision impairment prone to psychosocial problems

People with vision impairment prone to psychosocial problems

Experimental COVID-19 drug shows promising antiviral efficacy in Asians

Experimental COVID-19 drug shows promising antiviral efficacy in Asians

Loading, maintenance doses of teicoplanin need adjustments in MRSA patients

Loading, maintenance doses of teicoplanin need adjustments in MRSA patients

Share decision-making process with patients, says study

Share decision-making process with patients, says study

Modern urethroplasty offers long-term patency, patient satisfaction

Modern urethroplasty offers long-term patency, patient satisfaction

Adjuvant pembrolizumab holds promise in bladder cancer

Adjuvant pembrolizumab holds promise in bladder cancer